Getting started
Vaccine Characterisation
Eligibles ttrition plot
Vaccination campaign Characterisation
| CDM name | Cohort name | Variable name | Variable level | Estimate name |
Vaccination campaign
|
||||
|---|---|---|---|---|---|---|---|---|---|
| overall | A_2023 | A_2024 | S_2024 | S_2025 | |||||
| cdm_gold_202507 | vaccine_record | Number records | – | N | 6,799 | 2,822 | 2,394 | 1,064 | 519 |
| Number subjects | – | N | 3,620 | 2,822 | 2,394 | 1,064 | 519 | ||
| Cohort start date | – | Median [Q25 - Q75] | 2024-05-09 [2023-11-07 - 2024-11-04] | 2023-10-30 [2023-10-14 - 2023-11-20] | 2024-11-03 [2024-10-18 - 2024-11-22] | 2024-05-07 [2024-04-25 - 2024-05-20] | 2025-04-25 [2025-04-15 - 2025-05-02] | ||
| Range | 2023-10-03 to 2025-05-15 | 2023-10-03 to 2024-01-31 | 2024-10-03 to 2025-01-31 | 2024-04-15 to 2024-06-30 | 2025-04-01 to 2025-05-15 | ||||
| Cohort end date | – | Median [Q25 - Q75] | 2024-05-09 [2023-11-07 - 2024-11-04] | 2023-10-30 [2023-10-14 - 2023-11-20] | 2024-11-03 [2024-10-18 - 2024-11-22] | 2024-05-07 [2024-04-25 - 2024-05-20] | 2025-04-25 [2025-04-15 - 2025-05-02] | ||
| Range | 2023-10-03 to 2025-05-15 | 2023-10-03 to 2024-01-31 | 2024-10-03 to 2025-01-31 | 2024-04-15 to 2024-06-30 | 2025-04-01 to 2025-05-15 | ||||
| Region | London | N (%) | 7 (0.10%) | <5 | – | <5 | – | ||
| Northern ireland | N (%) | 587 (8.63%) | 244 (8.65%) | 209 (8.73%) | 95 (8.93%) | 39 (7.51%) | |||
| Scotland | N (%) | 3,948 (58.07%) | 1,546 (54.78%) | 1,487 (62.11%) | 610 (57.33%) | 305 (58.77%) | |||
| South east | N (%) | 17 (0.25%) | 12 (0.43%) | – | 5 (0.47%) | – | |||
| Wales | N (%) | 2,200 (32.36%) | 987 (34.98%) | 698 (29.16%) | 340 (31.95%) | 175 (33.72%) | |||
| West midlands | N (%) | 34 (0.50%) | 24 (0.85%) | – | 10 (0.94%) | – | |||
| Yorkshire & the humber | N (%) | 6 (0.09%) | 6 (0.21%) | – | – | – | |||
| Ethnicity | Asian | N (%) | 26 (0.38%) | 13 (0.46%) | 9 (0.38%) | <5 | <5 | ||
| Black | N (%) | <5 | <5 | – | – | – | |||
| White | N (%) | 3,070 (45.15%) | 1,301 (46.10%) | 1,078 (45.03%) | 473 (44.45%) | 218 (42.00%) | |||
| Sex | Female | N (%) | 3,681 (54.14%) | 1,544 (54.71%) | 1,276 (53.30%) | 577 (54.23%) | 284 (54.72%) | ||
| Male | N (%) | 3,118 (45.86%) | 1,278 (45.29%) | 1,118 (46.70%) | 487 (45.77%) | 235 (45.28%) | |||
| Imd | Q1 | N (%) | 983 (14.46%) | 357 (12.65%) | 369 (15.41%) | 155 (14.57%) | 102 (19.65%) | ||
| Q2 | N (%) | 1,022 (15.03%) | 450 (15.95%) | 360 (15.04%) | 148 (13.91%) | 64 (12.33%) | |||
| Q3 | N (%) | 2,007 (29.52%) | 849 (30.09%) | 662 (27.65%) | 344 (32.33%) | 152 (29.29%) | |||
| Q4 | N (%) | 1,932 (28.42%) | 790 (27.99%) | 711 (29.70%) | 287 (26.97%) | 144 (27.75%) | |||
| Q5 | N (%) | 855 (12.58%) | 376 (13.32%) | 292 (12.20%) | 130 (12.22%) | 57 (10.98%) | |||
| Age | – | Median [Q25 - Q75] | 74 [65 - 80] | 70 [60 - 77] | 71 [64 - 78] | 79 [76 - 85] | 81 [78 - 86] | ||
| Mean (SD) | 70.80 (14.41) | 67.08 (15.11) | 69.37 (13.78) | 78.91 (10.22) | 80.95 (8.13) | ||||
| Range | 6 to 105 | 6 to 104 | 7 to 101 | 19 to 105 | 20 to 101 | ||||
| Prior observation | – | Median [Q25 - Q75] | 7,353 [4,292 - 8,028] | 7,204 [3,977 - 7,747] | 7,565 [4,201 - 8,099] | 7,486 [5,167 - 8,114] | 7,829 [4,981 - 8,480] | ||
| Mean (SD) | 6,295.65 (2,866.34) | 6,072.61 (2,807.99) | 6,366.93 (2,919.18) | 6,544.94 (2,766.39) | 6,668.52 (3,041.01) | ||||
| Range | 5 to 13,194 | 6 to 12,830 | 5 to 13,194 | 7 to 12,585 | 20 to 12,897 | ||||
| Future observation | – | Median [Q25 - Q75] | 317 [177 - 537] | 549 [505 - 573] | 185 [162 - 205] | 365 [336 - 382] | 19 [12 - 30] | ||
| Mean (SD) | 324.20 (188.61) | 501.15 (123.69) | 177.22 (39.19) | 333.63 (81.00) | 20.76 (11.25) | ||||
| Range | 1 to 593 | 2 to 593 | 1 to 228 | 11 to 398 | 1 to 46 | ||||
| Days in cohort | – | Median [Q25 - Q75] | 1 [1 - 1] | 1 [1 - 1] | 1 [1 - 1] | 1 [1 - 1] | 1 [1 - 1] | ||
| Mean (SD) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | ||||
| Range | 1 to 1 | 1 to 1 | 1 to 1 | 1 to 1 | 1 to 1 | ||||
| Days to next record | – | Median [Q25 - Q75] | 199 [175 - 354] | 332 [197 - 378] | 184 [173 - 196] | 170 [159 - 185] | – | ||
| Mean (SD) | 246.37 (94.73) | 293.63 (94.50) | 180.81 (21.98) | 177.95 (41.76) | – | ||||
| Range | 92 to 569 | 92 to 569 | 93 to 217 | 105 to 377 | – | ||||
| Number visits in the prior year | – | Median [Q25 - Q75] | 26.00 [16.00 - 38.00] | 24.00 [14.00 - 36.00] | 25.00 [16.00 - 38.00] | 29.00 [19.00 - 42.00] | 30.00 [21.00 - 44.00] | ||
| Mean (SD) | 28.94 (18.87) | 27.20 (19.07) | 28.53 (18.39) | 32.26 (19.21) | 33.51 (17.79) | ||||
| Range | 0.00 to 200.00 | 0.00 to 200.00 | 0.00 to 132.00 | 0.00 to 140.00 | 1.00 to 100.00 | ||||
| Eligibles age | Vaccine record | N (%) | 4,185 (61.55%) | 1,856 (65.77%) | 918 (38.35%) | 924 (86.84%) | 487 (93.83%) | ||
| Eligibles immunosupressed | Vaccine record | N (%) | 120 (1.76%) | 45 (1.59%) | 37 (1.55%) | 26 (2.44%) | 12 (2.31%) | ||
| Number of prior vaccines | Vaccine record | Median [Q25 - Q75] | 4.00 [3.00 - 6.00] | 3.00 [3.00 - 5.00] | 4.00 [4.00 - 6.00] | 6.00 [5.00 - 6.00] | 8.00 [6.00 - 8.00] | ||
| Mean (SD) | 4.41 (1.78) | 3.47 (1.18) | 4.64 (1.76) | 5.24 (1.33) | 6.79 (1.98) | ||||
| Range | 0.00 to 9.00 | 0.00 to 6.00 | 0.00 to 8.00 | 0.00 to 8.00 | 0.00 to 9.00 | ||||
Plots
Overall Vaccination
Vaccination Campaigns
